Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Prognosis of survival"'
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 2089-2102 (2024)
Yanxia He,1,* Zhumei Luo,1,* Haoqing Chen,2,3,* Liqing Ping,2,3 Cheng Huang,2,3 Yan Gao,2,3 Huiqiang Huang2,3 1Department of Oncology, The Third People’s Hospital of Chengdu, Sichuan, People’s Republic of China; 2State Key Laboratory
Externí odkaz:
https://doaj.org/article/ea6d309ec65548b08aba7d9709b944d1
Autor:
Luis F. Oñate-Ocaña, Roberto Herrera-Goepfert, Alejandro Avilés-Salas, Carlo C. Cortés, Sagrario González-Trejo, José F. Carrillo, Erika Ruiz-García, Francisco J. Ochoa-Carrillo, Vincenzo Aiello-Crocifoglio, Claudia M. García-Cuellar
Publikováno v:
Revista de Investigación Clínica, Vol 75, Iss 5 (2023)
Background: Colorectal cancer is the most frequent gastrointestinal malignancy worldwide. The value of adjuvant treatment is controversial in Stages I and II. Objective: The aim of this study was to construct post-operative prognostic models applicab
Externí odkaz:
https://doaj.org/article/1dc986d539004c9ab4d9930eb098cd3d
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 8, Iss 3, Pp 21-33 (2021)
Purpose of the study. This research was devoted to study of mRNA and miRNA expression patterns in glioglastomas using The Cancer Genome Atlas (TCGA) data, to search for genetic determinants that determine the prognosis of patient survival and to crea
Externí odkaz:
https://doaj.org/article/bb9b6472c5dc46738b5b452f3f3981b5
A non-lab nomogram of survival prediction in home hospice care patients with gastrointestinal cancer
Autor:
Muqing Wang, Xubin Jing, Weihua Cao, Yicheng Zeng, Chaofen Wu, Weilong Zeng, Wenxia Chen, Xi Hu, Yanna Zhou, Xianbin Cai
Publikováno v:
BMC Palliative Care, Vol 19, Iss 1, Pp 1-11 (2020)
Abstract Background Patients suffering from gastrointestinal cancer comprise a large group receiving home hospice care in China, however, little is known about the prediction of their survival time. This study aimed to develop a gastrointestinal canc
Externí odkaz:
https://doaj.org/article/b6617d572e5f497591c5f8bcaccc12c1
Publikováno v:
Journal of Medical Biochemistry, Vol 39, Iss 2, Pp 160-164 (2020)
Background: We investigated the prognostic value of the preoperative lymphocyte-to-mononuclear ratio (LMR) and platelet-to-lymphocyte ratio (PLR) in a large cohort of patients with non-small cell lung cancer (NSCLC). Methods: Clinical-pathological da
Externí odkaz:
https://doaj.org/article/9804ae0c8b794afc8ea311b1f701bd18
Autor:
Yi Xiao, Jinyuan He, Shaoning Luo, Min Dong, Wei Li, Gaijiao Liu, Hongjie Chen, Xiongwen Yang, Shaohong Huang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Pulmonary lymphoepithelioma-like carcinoma (pLELC) is a rare subtype of lung cancer that is associated with the Epstein-Barr virus in Asia. Due to the lack of prospective studies, the best first-line treatment and survival outcomes remain unclear. He
Externí odkaz:
https://doaj.org/article/02465a2eb85948b7b01278f1c512666d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Medical Biochemistry, Vol 39, Iss 2, Pp 160-164 (2020)
J Med Biochem
J Med Biochem
We investigated the prognostic value of the preoperative lymphocyte-to-mononuclear ratio (LMR) and platelet-to-lymphocyte ratio (PLR) in a large cohort of patients with non-small cell lung cancer (NSCLC).Clinical-pathological data from 507 NSCLC pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc4f034b3b1906a92094f45801ee711c
https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2020/1452-82582002160Y.pdf
https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2020/1452-82582002160Y.pdf
Autor:
Marasco, G, Colecchia, A, Bacchi Reggiani ML, Celsa, C, Farinati, F, Giannini, Eg, Benevento, F, Rapaccini, Gl, Caturelli, E, Di Marco, M, Biasini, E, Marra, F, Morisco, F, Foschi, Fg, Zoli, M, Gasbarrini, A, Baroni, Gs, Masotto, A, Sacco, R, Raimondo, G, Azzaroli, F, Mega, A, Vidili, G, Brunetto, Mr, Nardone, G, Dajti, E, Ravaioli, F, Avanzato, F, Festi, D, Trevisani, F, group, Italian Liver Cancer (ITA. LI. CA.
Background: Sorafenib is the gold standard therapy for the advanced hepatocellular carcinoma (HCC). No scoring/staging is universally accepted to predict the survival of these patients. Aims: To evaluate the accuracy of the available prognostic model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dadf7662451833197fdc66d47ecdf02
http://hdl.handle.net/11577/3401821
http://hdl.handle.net/11577/3401821
